INTRODUCTION {#s1}
============

Metabolic syndrome is characterized by the simultaneous presence of interrelated metabolic risk factors, such as visceral obesity, high blood pressure and carbohydrate and lipid metabolism abnormalities[@b1], and it leads to an increased risk for type 2 diabetes mellitus and cardiovascular diseases[@b2],[@b3]. Although the criteria used to diagnose the metabolic syndrome may be different, several studies have demonstrated that the prevalence of metabolic syndrome has increased dramatically in the past two decades[@b4]--[@b6]. Metabolic syndrome is subjected to multifactorial influences including both environmental and genetic factors. Current researches focus more on the cause of one or certain metabolic syndrome components, but rarely pay attention to the etiology of metabolic syndrome.

Reportedly, adiponectin is an adipose tissue-derived cytokine with anti-inflammatory, anti-atherogenic and cardioprotective properties. Increasing evidence suggested that adiponectin, linked to central obesity and insulin resistance, is a key contributor to the development of metabolic syndrome[@b7]. The *ADIPOQ* gene encoding adiponectin is located on chromosome 3q27 and this chromosome region had been mapped as a susceptibility locus for metabolic syndrome and coronary heart disease by genome-wide scans[@b8]. There are specific functional peroxisome proliferator response elements (PPREs) in the promoter region of adiponectin. *PPAR-γ* binds to PPREs as a heterodimer with members of the *retinoid X receptor* (*RXR*) nuclear receptor subfamily[@b9], and increases adiponectin promoter activity in cells from humans[@b10]. The expression of adiponectin in the adipose tissue is maintained and induced by direct binding of endogenous or exogenous *PPAR-γ/RXR* heterodimer to the PPRE in the adiponectin promoter[@b10]. Therefore, the *PPAR-γ* and *RXR-α* genes in the adiponectin pathway are candidates for obesity and metabolic syndrome.

The back-error propagation artificial neural network (BPANN) is a computer-based algorithm that is trained to recognize and categorize complex patterns. BPANN as a new approach to etiology research avoids the limitations of case control study and logistic regression without the distribution form and independence of variables. Our group has previously found the association of single nucleotide polymorphisms (SNPs) in the*PPAR-γ* and *RXR-α* genes with metabolic syndrome or type 2 diabetes risks in different populations[@b11],[@b12]. In the present study, we further explored the application characteristics of BPANN in studying the combined effects of genetic variants in the *PPAR-γ* and *RXR-α* gene and metabolic syndrome risks in a Chinese Han population. We compared the results of BPANN with those of traditional logistic regression analysis to better understand and use artificial neural network in the study of diseases of multiple etiologies.

SUBJECTS AND METHODS {#s2}
====================

Subjects {#s2a}
--------

A total of 2,081 Chinese patients, including 1,012 metabolic syndrome and 1,069 non-metabolic syndrome controls, were recruited for metabolic studies with their informed consent. The protocol was approved by the Research Ethics Committee of Nanjing Medical University. All participants were genetically unrelated ethic Han Chinese. The cases were consecutively recruited from the inpatient or outpatient departments of three affiliated hospitals of Nanjing Medical University (the Second Affiliated Changzhou Hospital, the Third Affiliated Hospital and the First Affiliated Hospital) between March 2008 and August 2010, without any restriction on age and sex (430 males and 582 females with a mean age of 55.35±10.62 years). Age (±5 years) and sex-matched non-metabolic syndrome controls who underwent routine annual health examinations within the same geographical area and the period (478 males and 591 females with a mean age of 55.78±13.10 years) were also recruited for the study. In order to collect demographic data and information in environmental exposure history, each participant was interviewed face-to-face using a standard questionnaire. After the interview, 5 mL venous blood sample was collected from each participant. The level of physical activity was defined as walking or riding ≥ 15 minutes/day and/or lifting or carrying heavy objects at work daily and/or doing sports or physical exercise \> 2 hours/week. Tobacco smokers were defined as patients who smoked at least one cigarette per day for over 1 year. Alcohol drinkers were defined as those who had the sum of milliliters of alcohol per week from wine, beer, cider or spirits.

The new (2009) criteria of metabolic syndrome was based on a joint interim statement of the International Diabetes Federation (IDF); National Heart, Lung and Blood Institute (NHLBI); American Heart Association (AHA); World Heart Federation; International Atherosclerosis Society and International Association, which define metabolic syndrome as the presence of three or more of the following features: triglycerides (TG)≥150 mg/dL (1.7 mmol/L) (or drug treatment for elevated triglycerides), high-density lipoprotein cholesterol (HDL-C) \< 40 mg/dL (1.0 mmol/L) in mates and \< 50 mg/dL (1.3 mmol/L) in females (or drug treatment for reduced HDL-C), fasting plasma glucose (FPG)≥100 mg/dL (or drug treatment for elevated glucose), systolic blood pressure (SBP)≥130 and/or diastolic blood pressure (DBP)≥85 mmHg (or antihypertensive drug treatment in a patient with a history of hypertension), and waist circumstances (WC)≥85 cm in men and 80 cm in women (current recommended waist circumstance thresholds for abdominal obesity for people in China)[@b13].

Measurements {#s2b}
------------

Weight and height were measured by trained personnel, and body mass index (BMI, in kg/m^2^) was calculated. Blood pressure was measured on the right arm, with the patient in a sitting position and after a minimum 10-min rest, using a standard mercury sphygmomanometer. After an overnight fast, venous blood samples were drawn and promptly centrifuged and the plasma was stored at -20°C. Serum adiponectin, FPG and TC, HDL-C, LDL-C and TG were analyzed using human adiponectin ELISA kit (RapidBio Co., Calabasas, CA, USA), glucose oxidase method and enzymatic colorimetric method (Au5400; Olympus, Japan), respectively. DNA was extracted from blood samples by using a phenol-chloroform technique. All measurements were conducted by the manufacturers\' protocols.

SNP selection and genotyping {#s2c}
----------------------------

In the present study, we first used NCBI dbSNPs database (<http://www.ncbi.nlm.nih.gov/>), the public HapMap SNP database (<http://www.hapmap.org/>) and previously reported literatures to identify potentially functional SNPs of the *PPAR-γ* and *RXR-α* gene. Three potentially functional SNPs of the *PPAR-γ* gene (rs2920502, rs3856806 and rs1801282) and four of the *RXR-α* gene (rs1045570, rs3132291, rs4240711 and rs4842194) with minor allele frequency (MAF)≥0.05 in the Chinese Han population were identified, including four at the coding region and three at the 3′ untranslated region. Then, we used public HapMap SNP database to identify *PPAR-γ* and *RXR-α* gene tagging SNPs by using tagger with greedy algorithm. Finally, two tagging SNPs (rs17817276 and rs38566806) of the PPAR-γ gene and two of the RXR-α gene (rs1045570 and rs6537944) were selected based on pair-wise tagging (r^2^ ≥0.80, MAF ≥0.05) by using genotype data from unrelated HapMap CHB individuals. Genomic sequences were obtained from the HapMap database. Primer version 5.0 and polymerase chain reaction (PCR) primer-introduced restriction analysis were used to design the nine primer sets ***([***Table 1***](#jbr-28-02-114-t01){ref-type="table"})***.

Genetic analyses were performed on genomic DNA extracted from leucocytes of venous blood. We used the TaqMan allelic discrimination assay to genotype the polymorphisms on the platform of 7900HT Real-time PCR System (Applied Biosystems, Foster City, CA). The information on assay conditions and the primers and probes are available upon request. Two negative controls were included in each 384-well reaction plate and individual genotype identification were determined by SDS software 2.0 (ABI). Moreover, to confirm genotyping results, 10% of samples were randomly selected to repeat the procedure and the results were 100% concordant.

###### Primers and annealing temperature used for RET sequencing

       SNP        Primers                             Probes   
  ------------- ----------- ------------------------ --------- ------------------------
     PPAR-γ                                                    
    rs17817276     Sense      CTCCCTGACAGCAGCTATCC    Probe 1   AAATAGTAATATATGACAACCT
                 Antisense   TTCCCAGGATTATCCTAACAGA   Probe 2    AATAGTAATACATGACAACC
    rs3856806      Sense       TGTTTGCCAAGCTGCTCC     Probe 1       CTGCACGTGTTCC
                 Antisense     TTGGCAGTGGCTCAGGAC     Probe 2       CTGCACATGTTCC
    rs1801282      Sense     TGCTGTTATGGGTGAAACTCTG   Probe 1      CTATTGACCCAGAAAG
                 Antisense   ATAGCCGTATCTGGAAGGAACT   Probe 2      CTATTGACGCAGAAAG
    rs2920502      Sense       GCACAGTAGGGCCCACG      Probe 1       CCACTCTCTGCCC
                 Antisense    GGATCCCTCCTCGGAAATG     Probe 2       CCACTGTCTGCCC
      RXR-α                                                    
    rs6537944      Sense     CGTGAATGCTGCTCTCTCTGT    Probe 1       CGTTCCGTCAGGCA
                 Antisense    AACTGGATATGGGCAGCACT    Probe 2       CGTTCCATCAGGCA
    rs1045570      Sense      AGCCTTGCTCTGTTGTGTCC    Probe 1       CACCTGCGGCCAC
                 Antisense    ACTTCTCCCTTTGCGTGTTC    Probe 2       CACCTGAGGCCAC
    rs4842194      Sense       TGGTGGAAATGGCAGGAG     Probe 1       TGCCTTCTGCAGCC
                 Antisense     CCCTGGGCTTTTTCCTCT     Probe 2       TGCCTTCTGCAGCC
    rs3132291      Sense     CTTCAGTGTGTCTGGTGCCTC    Probe 1       AGGGCTCCGGGCA
                 Antisense   GCATTGTCTCCTGTGATAAACG   Probe 2       AGGGCTCTGGGCA
    rs4240711      Sense      GACTCCCCGTTCAGACCAG     Probe 1      AGGACAAGTCTCAGC
                 Antisense     CTCCAGCAAGGCCAGTGA     Probe 2      AGGACAAGCCTCAGC

Statistical analysis {#s2d}
--------------------

Hardy-Weinberg equilibrium was assessed within controls using the goodness-of-fit χ^2^ test. The distribution of the general characteristics between metabolic syndrome and non-metabolic syndrome controls was compared by using two-sided Chi-square test and/or Student\'s *t* test. The significance level was set at *P* \< 0.05. Both univariate and multiple logistic regression analyses were performed to estimate crude and adjusted standardized partial regression coefficient (β), odds ratios (ORs) and 95% confidence intervals (CIs) for the association between genotypes and metabolic syndrome risks. All statistical analyses were performed by SPSS software (SPSS version 13.0, Chicago, IL, USA). Generalized multifactor dimensionality reduction (GMDR) software (version 1.0.1) ([www.healthsystem.virginia.edu/internet/Addiction-Genomics/](www.healthsystem.virginia.edu/internet/Addiction-Genomics/)) was applied for detecting gene-gene and gene-environment interactions[@b14]. BPANN prediction model was established and each input neurons\' mean impact value (MIV) was calculated using MATLAB7.0 software (MathWorks, Natick, MA)[@b15].

RESULTS {#s3}
=======

Univariate logistic regression analysis of associations between risk factors and metabolic syndrome {#s3a}
---------------------------------------------------------------------------------------------------

The clinical characteristics of the 2081 subjects are shown in [***Table 2***](#jbr-28-02-114-t02){ref-type="table"}. The genotype distributions of all the SNPs satisfied Hardy-Weinberg equilibrium (all *P* \> 0.05 in controls). The associations between the 19 variables, including four of the *PPAR-γ* gene, five of the *RXR-α* gene, serum adiponectin concentration and other environmental factors, was estimated by binary logistic regression analysis. [***Table 3***](#jbr-28-02-114-t03){ref-type="table"} shows the sequences of the impact of various factors on metabolic syndrome risk. The top ten were family history of hyperlipidemia or type 2 diabetes, physical activity, family history of hypertension, BMI, alcohol drinking, gender, rs6537944, rs1801282 and rs4842194.

Multiple logistic regression analysis of associations between risk factors and metabolic syndrome {#s3b}
-------------------------------------------------------------------------------------------------

Multiple logistic regression analysis was performed to determine the association between the 19 variables and metabolic syndrome with the stepwise regressive method (the removal probability was 0.1). [***Table 4***](#jbr-28-02-114-t04){ref-type="table"} illustrates nine factors in the best model and only six factors were statistically significant, including family history of type 2 diabetes or hyperlipidemia, physical activity, gender, alcohol drinking, BMI, rs4240711, rs2920502 and serum adiponectin.

BPANN multiple analysis of associations between risk factors and metabolic syndrome {#s3c}
-----------------------------------------------------------------------------------

We used 19 factors as input variables and metabolic syndrome diagnosis as output variables to establish model with all available samples. The transfer function was logsig function. Learning rate and training error were 0.1 and 0.01, respectively. Training steps were set to a maximum of 1000 steps. After the completion of training, the MIV was obtained. [***Table 5***](#jbr-28-02-114-t05){ref-type="table"} summarizes all related factors, consisting of BMI, serum adiponectin, rs4240711, gender, rs4842194, family history of diabetes, rs2920502, physical activity, alcohol drinking, rs3856806, family history hypertension, rs1045570, rs6537944, age, rs17817276, family history of hyperlipidemia, smoking, rs1801282 and rs3132291 in sequence of the absolute value of MIV.

###### Basic characteristics of the case and control groups

        Variables         Case (*n* =1, 012)   Control (*n* =1, 069)   *P*-value
  ---------------------- -------------------- ----------------------- -----------
   Gender (male:female)        430:582                478:591          \< 0.306
       Age (years)           55.35±10.62            55.78±13.10        \< 0.409
        SBP (mmHg)           137.26±18.85          124.112±18.42       \< 0.001
        DBP (mmHg)           85.26±11.08            77.33±10.11        \< 0.001
         WC (cm)              88.58±9.28            78.73±8.57         \< 0.001
      BMI (kg/m^2^)           25.79±3.44            23.31±2.94         \< 0.001
       TC (mmol/L)            5.22±1.24              4.90±0.92         \< 0.001
       TG (mmol/L)            2.71±2.40              1.24±0.73         \< 0.001
      HDL-C (mmol/L)          1.16±0.40              1.45±0.37         \< 0.001
      LDL-C (mmol/L)          2.733±0.98             2.56±0.83         \< 0.001
       FPG (mmol/L)           8.86±3.95              5.88±2.79         \< 0.001
    Adiponectin (mg/L)        6.76±2.57              7.00±2.66         \< 0.045
      T2DM (*n*, %)           832(82.4)              287(26.9)         \< 0.001
     Obesity (*n*, %)         720(72.7)              212(20.1)         \< 0.001

Data are mean ± SD values except as marked. SBP: systolic blood pressure; DBP: diastolic blood pressure; WC: waist circumstances; BMI: body mass index; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FPG: fasting plasma glucose; TC: total cholesterol; T2DM: type 2 diabetes mellitus.

###### Univariate logistic regression analysis results

             Variables               β          OR (95%CI)        *P*-value   Rank
  ------------------------------- -------- --------------------- ----------- ------
   Hyperlipidemia family history   -1.349   3.854 (1.653,8.989)     0.002      1
        T2DM family history        -1.098   2.999 (2.116,4.250)   \< 0.001     2
         Physical activity         -0.651   0.522 (0.381,0.714)   \< 0.001     3
    Hypertension family history    -0.324   1.383 (1.076,1.777)     0.011      4
                BMI                -0.273   1.314 (1.254,1.377)   \< 0.001     5
         Alcohol drinking          -0.198   1.219 (0.895,1.660)     0.208      6
              Gender               -0.192   0.825 (0.648,1.050)     0.118      7
             rs6537944             -0.171   0.843 (0.633,1.122)     0.242      8
             rs1801282             -0.161   0.851 (0.591,1.227)     0.387      9
             rs4842194             -0.116   0.891 (0.700,1.134)     0.348      10
             rs3856806             -0.105   0.900 (0.707,1.147)     0.395      11
             rs3132291             -0.093   0.911 (0.716,1.160)     0.45       12
              Smoking              -0.085   1.089 (0.809,1.467)     0.574      13
             rs2920502             -0.082   1.085 (0.896,1.314)     0.404      14
         Serum adiponectin         -0.076   0.927 (0.887,0.970)     0.001      15
            rs17817276             -0.065   1.067 (0.816,1.396)     0.634      16
             rs1045570             -0.023   1.023 (0.797,1.312)     0.859      17
             rs4240711             -0.012   0.988 (0.774,1.262)     0.924      18
                Age                -0.01    0.990 (0.978,1.002)     0.106      19

\*rank was according to the absolute value of β. BMI: body mass index.

GMDR for the combined effect of the *PPAR-γ* and *RXR-α* gene {#s3d}
-------------------------------------------------------------

The SNPs rs4240711, rs4842194, rs2920502 and rs3856806, which were obtained in the top ten in BPANN multiple analysis, were named as A~1~, A~2~, B~1~ and B~2~ in turn. GMDR that evaluated the combined effect of the four SNPs detected A~1~, A~2~, B~1~ and B~2~ (rs4240711, rs4842194, rs2920502 and rs3856806) model as the best model (Cross-validation consistency 10/10, *P* = 0.0447) ***([***Table 6***](#jbr-28-02-114-t06){ref-type="table"})***. After controlling for age, gender, smoking, alcohol drinking and physical activity, the results showed that A~1~, A~2~, B~1~ and B~2~ model still were the best model from GMDR (Cross-validation consistency 10/10, *P* = 0.0107) ***([***Table 7***](#jbr-28-02-114-t07){ref-type="table"})***. However, we failed to obtain a significant model when all the nineteen SNPs were added into the analysis (Cross-validation consistency 10/10, *P* = 0.1719) (data not shown).

DISCUSSION {#s4}
==========

Metabolic syndrome, like virtually all human diseases, results from the interactions between genetic and environmental factors. Environmental factors such as obesity, low levels of physical activity and inappropriate dietary habits are strong determinants of metabolic syndrome[@b16],[@b17]. Traditional statistical methods due to their own limitation do not show the real relationship between gene and environmental elements with the risk of metabolic syndrome. Binary logistic regression analysis, for example, was used to analyze the association between the 19 variables and metabolic syndrome. [***Table 3***](#jbr-28-02-114-t03){ref-type="table"} showed that the locant, according to standardized partial regression coefficient (β) of each variable, of top six environmental factors was hyperlipidemia family history, family history of type 2 diabetes, physical activity, smoking, family history of hypertension and BMI. Relative to environmental factors, the contribution of gene polymorphisms to the susceptibility and causation of diseases was hidden and weaker. Binary logistic regression limited to analyzing the combined action of elements did not provide the evidence for gene-environment interaction.

###### Multiple logistic regression analysis results

             Variable                β          OR (95%CI)        *P*-value   Rank
  ------------------------------- -------- --------------------- ----------- ------
        T2DM family history        -1.197   3.309 (2.253,4.861)   \< 0.001     1
   Hyperlipidemia family history   -1.184   3.267 (1.297,8.228)     0.012      2
         Physical activity         -0.712   0.491 (0.342,0.705)   \< 0.001     3
              Gender               -0.306   0.736 (0.560,0.968)     0.028      4
         Alcohol drinking          -0.355   1.426 (0.957,2.125)     0.081      5
                BMI                -0.302   1.353 (1.287,1.422)   \< 0.001     6
             rs4240711             -0.249   1.283 (0.968,1.700)     0.083      7
             rs2920502             -0.241   0.786 (0.595,1.038)     0.089      8
         Serum adiponectin         -0.076   0.927 (0.881,0.976)     0.004      9

\*rank was according to the absolute value of β. BMI: body mass index.

###### Input variables and sorting of mean influence values (MIV)

        Variable            MIV      Rank  Variable                            MIV      Rank
  --------------------- ----------- ------ ------------------------------- ----------- ------
           BMI           -0.034326    1    Hypertension family history      -0.000995    11
    Serum adiponectin    -0.007267    2    rs1045570                        -0.000824    12
        rs4240711        -0.006018    3    rs6537944                        -0.000704    13
         Gender          -0.004006    4    Age                              -0.000550    14
        rs4842194        -0.003670    5    rs17817276                       -0.000512    15
   T2DM family history   -0.003157    6    Hyperlipidemia family history    -0.000448    16
        rs2920502        -0.002862    7    Smoking                          -0.000437    17
    Physical activity    -0.002435    8    rs1801282                        -0.000256    18
    Alcohol drinking     -0.001404    9    rs3132291                        -0.000062    19
        rs3856806        -0.001272    10                                               

BMI: body mass index; T2DM: type 2 diabetes mellitus.

By using the maximum likelihood method, only six variables were statistically significant, including family history of type 2 diabetes and hyperlipidemia, physical activity, gender, BMI and serum adiponectin. The result of multiple logistic regression analysis did not detect the role that *PPAR-γ* gene and *RXR-α* gene polymorphisms played in the development of metabolic syndrome, but BPANN analysis had proved the association[@b12]. Adiponectin has an obvious protective effect on metabolic syndrome and its cardiovascular complications[@b18], but the contribution of adiponectin was weakened in the model, because of the complex interaction between variables.

Artificial neural networks are a non-linear pattern recognition algorithm consisting of a group of processing units that simulate the function of neurons in human brain and reveal relationships among the input data that cannot always be recognized by conventional models[@b19]. In recent years, artificial neural networks have been increasingly used in complex medical decision-making, such as the diagnosis of various diseases, investigating the predictive values of disease risk factors and analyzing the complex relationships between gene-environment[@b20],[@b21]. BPANN has not only been the core of feedforward neural networks, but also embodied the essence of artificial neural networks[@b15]. The units in a BPANN are highly interconnected by weighted links, very similar to neural synapses. In the constant learning process in which the former feedback of error was used to modify corresponding weights and threshold value, BPANN adjusted the weights of links between neurons in order to associate input data with correct output (such as disease diagnosis). BPANN could fully show all the relationship between factors in a simulation. Therefore, we further used BPANN to identify the real association between *PPAR-γ* and *RXR-α* gene polymorphisms with susceptibility to metabolic syndrome in southern Han Chinese and the key risk factors for metabolic syndrome. Compared to logistic regression analysis, BPANN showed a better understanding of using artificial neural network in epidemiology. Compared with the results of univariate and multiple logistic regression analyses, the seating arrangements of BMI and serum adiponection concentration were obviously raised in BPANN analysis. The sequence of serum adiponection concentration was raised to the second factor only after BMI from the last sequence in multiple logistic regression analysis. Central obesity is considered a pivotal component in metabolic syndrome. Even in subjects without obesity, a higher BMI tends to correlate with a higher number of positive metabolic syndrome components[@b22]. It has been reported that adiponectin concentration was an important predictor for the risk of metabolic syndrome[@b23]. Our result further validated that adiponectin had a great influence on the pathogenesis of metabolic syndrome.

###### The GMDR models for *PPAR-γ* and *RXR-α* gene interaction on metabolic syndrome

          Model          Training Bal.Acc.   Test Bal.Acc.   CV consistency   *P*-value
  --------------------- ------------------- --------------- ---------------- -----------
          B~2~                0.5213            0.4955            8/10         0.3770
        A~2~ B~2~             0.5359            0.5065            6/10         0.6230
     A~2~ B~1~ B~2~           0.5612            0.4907            6/10         0.8281
   A~1~ A~2~ B~1~ B~2~        0.5857            0.5333           10/10         0.0447

A~1~: rs4240711; A~2~: rs4842194; B~1~: rs2920502; B~2~: rs3856806; CV: cross-validation.

###### The GMDR models for *PPAR-γ* and *RXR-α* gene-environment interaction on metabolic syndrome

          Model          Training Bal.Acc.   Test Bal.Acc.   CV consistency   *P*-value
  --------------------- ------------------- --------------- ---------------- -----------
          B~2~                0.5243            0.5062            9/10         0.1719
        A~2~ B~2~             0.5392            0.4958            6/10         0.8281
     A~2~ B~1~ B~2~           0.5653            0.4944            6/10         0.9453
   A~1~ A~2~ B~1~ B~2~        0.5901            0.5352           10/10         0.0107

A~1~: rs4240711; A2: rs4842194; B~1~: rs2920502; B~2~: rs3856806; CV: cross-validation.

*PPAR-γ* rs2920502, rs3856806 and *RXR-α* rs4240711, rs4842194 had no association with metabolic syndrome in univariate and multiple logistic regression analyses, but the seating arrangements of the four gene polymorphisms were in front in BPANN analysis, which implied an association between the four genetic variants in *PPAR-γ* and *RXR-α* and metabolic syndrome. Currently, the studies investigating the associations between rs2920502, rs4240711 and rs4842194 polymorphisms and the risk of metabolic syndrome have been reported rarely. In a previous study[@b12], we also found that those carrying rs2920502CG and CG/GG genotype had a significantly increased risk of metabolic syndrome and rs4240711GG and AG/GG, rs4842194 CC and CT/CC genotypes were all associated with prominent protective effects for metabolic syndrome. Up to now, numerous studies have focused on the association between C1431T variant (rs3856806) of *PPAR-γ* and the risk of metabolic syndrome, type 2 diabetes and obesity in several populations[@b24]--[@b26], but the conclusions are conflicting. Li et al.[@b24] reported that polymorphism C1431T of exon 6 of *PPAR-γ* was associated with metabolic syndrome risks in a Chinese population study of 423 cases with metabolic syndrome and families without metabolic syndrome. However, in another study of 792 Han Chinese in Beijing, Dongxia et al.[@b27] failed to show the association, but a significant association between rs3856806 and insulin resistance. In a population-based study of 1910 subjects by our group, divided according to the IDF (2005) criteria, we also did not find differences of rs3856806 among metabolic syndrome patients and non-metabolic syndrome controls by logistic regression analysis[@b12]. In Meirhaeghe\'s French population study[@b17], the C1431T variant was only connected with the other three polymorphisms, including P3-681C \> G, P2-689C \> T, Pro12Ala, and the GTGC haplotype was associated with metabolic syndrome. It may be that the individual C1431T\'s role in the pathogenesis of metabolic syndrome is not obvious and the combined effect with other polymorphisms exists, but the traditional statistical methods do not show.

No polymorphisms in the two genes had been found to associate with metabolic syndrome in univariate and multiple logistic regression analyses, but the seating arrangements of the four gene polymorphisms were in front in BPANN analysis. The finding of BPANN analysis and logistic regression analysis suggested that the interactions between four SNPs may be associated with the risk of metabolic syndrome. We used the GMDR method to indentify the combined effect of the four SNPs (rs2920502, rs3856806, rs4240711 and rs4842194). The GMDR is an extended version of the multifactor dimensionality reduction approach, which allows high-dimensional interactions of multiple factors to be simultaneously retrieved. The GMDR method is a non-parametric and genetic model-free approach that efficiently identifies higher-order interactions between genes and/or gene-environmental factors with both dichotomous and continuous phenotypes in various population-based study designs. The main idea of GMDR is to reduce multi-dimensional genotypes into one-dimensional binary attributes by pooling genotypes of multiple SNPs using a well-defined classifier[@b14]. Furthermore, GMDR can reduce the complexity substantially and permit adjustment for discrete and quantitative covariates[@b14]. GMDR has been performed to successfully identify the combinations of SNPs that significantly influenced complex diseases[@b28]. The model of A1, A2, B1 and B2 (rs4240711, rs4842194, rs2920502 and rs3856806) were the best model (Cross-validation consistency 10/10, *P* = 0.0447). It showed that four SNPs loci interact with one another and suggested interactions between the two genes. After controlling age, gender, smoking, alcohol drinking and physical activity, the results showed that A~1~, A~2~, B~1~ and B~2~ (rs4240711, rs4842194, rs2920502 and rs3856806) model were still the best model as the highest Test Balanced Accuracy (0.5901) (Cross-validation consistency 10/10, *P* = 0.0107). After adjusting age, gender, smoking, alcohol drinking and physical activity, the combined effect of *PPAR-γ* gene and *RXR-α* gene still existed. PPAR-γ acts as a nuclear receptor-transcription factor by forming a heterodimer with RXR. PPAR-γ/RXR heterodimer directly binds to the functional PPAR-responsive element (PPRE) and increases human adiponectin promoter activity in cells. The *PPAR-γ* gene and *RXR-α* gene are related to the adiponectin-signal transduction pathway. The two genes may play a significant role in insulin resistance, which is a key feature of metabolic syndrome and type 2 diabetes by affecting adiponectin secretion levels.

BPANN is designed to detect patterns in input data, which may match output data even if the nature of such patterns is not known a priori; thus, all richer relations between factors can be simulated and provided at a time than the ordinary model[@b29]. Simultaneously, BPANN not requiring the distribution form and independence of variables, also can handle the problem of collinearity better. Compared with the traditional analysis methods, BPANN may be better suited to predict outcomes when the relationships between the variables are complex, multidimensional and nonlinear in complex biological systems[@b30]. Neural network models have the ability to detect all possible interactions between predictive variables and provide a model consistent with practical situations. Even so, BPANN analysis was a "black box" and had limited ability to explicitly identify possible causal relationships[@b31]. The model builder of logistic regression was able to select variables which were most strongly predictive of an outcome based on the magnitude of the standardized partial regression coefficients (β) and the associated odds ratios.

In this article, we put four SNPs, which was selected by BPANN analysis, into model analyses by GMDR software. We obtained an optimal model with statistical significance. The result suggested an interaction between the *RXR-α* gene and *RXR-α* gene. However, we failed to obtain an optimal model when all the 19 SNPs were included in the analysis without screening. Therefore, we conclude that BPANN can be used to select influence factors commonly, especially for early screening of genetic factors. We can further analyze gene interactions by using the results of screening, according to the ranking list of MIV as a relative stable reference.
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